Purchase Order AG5405P170013
- Not listed
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, was awarded a $20,297.72 firm fixed-price delivery order by the Bureau of Medicine and Surgery (an element of the Department of Defense) on February 11, 2020, with an ultimate completion date of February 18, 2021. The contract covers service maintenance on a BD FACSCanto II flow cytometer (serial number V96101183), a sophisticated instrument used for cell analysis and research applications. The work will be...
- Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, was awarded a delivery order valued at $11,776.68 on November 18, 2004, for a FACSoft/4 color 5-day service contract. The contract was performed in Bethesda, Maryland and completed by September 30, 2005. This delivery order was issued without small business set-aside designation, reflecting BD's competitive standing as a large medical technology manufacturer. As a child contract under a larger vehicle, this...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, was awarded a delivery order contract valued at $11,385.00 by a federal agency for maintenance services on a FACScan flow cytometry instrument (Serial Number 81449). The contract was awarded on October 1, 2006, with an ultimate completion date of September 30, 2007, and will be performed in Bethesda, Maryland. This award was made on a full and open competition basis without small business set-aside...
- Becton, Dickinson and Company (BD), through its BD Biosciences division, was awarded a purchase order by a civilian federal agency's Office of Acquisitions and Grants for preventive maintenance and repair services on a Becton Dickinson Immunocytometry System Flow Cytometer (serial number E97500138) located in Lafayette, Louisiana. The contract, valued at $5,246.25 under a firm fixed-price arrangement, was awarded on August 25, 2023, with an ultimate completion date of August 29, 2024. The...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, received a delivery order contract valued at $11,385.00 for a five-day maintenance agreement on a FACScan instrument system, with performance in Bethesda, Maryland. The contract was awarded on October 1, 2006, with an ultimate completion date of September 30, 2007. This delivery order was issued without a small business set-aside designation, reflecting BD's established competitive position in providing...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, received a $5,000 firm fixed price purchase order from the Bureau of Medicine and Surgery (Naval Medical) for repair services, with an ultimate completion date of May 29, 2015. This non-set-aside contract was awarded on April 29, 2015 and will be performed in San Jose, California. BD Biosciences specializes in providing sophisticated flow cytometry instruments, cell imaging technologies, reagents, and...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, was awarded a delivery order contract on October 17, 2006, for maintenance services on FACS-CAL IBUR 4 Color flow cytometry equipment with a five-day service week. The contract, valued at approximately $21.4K with an ultimate completion date of September 30, 2007, was awarded without a small business set-aside designation. The place of performance is located in Bethesda, Maryland, which aligns with the...
- Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, was awarded a delivery order contract valued at $10,258.92 on October 1, 2006, for service-related items under the FACSCALIBUR 4 CLR 5 DAY contract with an ultimate completion date of September 30, 2007. The work is to be performed in Bethesda, Maryland, and the contract was awarded on a full and open competition basis with no small business set-aside designation. BD Biosciences specializes in flow...
- Becton, Dickinson and Company, through its BD Biosciences division, was awarded a firm fixed-price purchase order valued at $88,457.40 by the Bureau of Medicine and Surgery (a Defense agency component) on November 1, 2025, for maintenance services on FACSymphony A1 flow cytometry instruments and FACS Flow Supply System equipment. The contract specifies two instrument configurations identified by catalog model numbers and serial numbers, with an ultimate completion date of October 31, 2030,...
- Becton, Dickinson and Company (BD), through its BD Biosciences division, was awarded a delivery order valued at $10,529.92 under contract SN E5013 FACSC on October 1, 2006, with completion scheduled for September 30, 2007. This was a non-set-aside award for performance at the Bethesda, Maryland location. As a leading global medical technology company, BD Biosciences specializes in sophisticated flow cytometry instruments, cell imaging systems, reagents, and related technical support services...
Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, received a $5,000 firm fixed-price purchase order from the Midwest Area of a civilian federal agency for repair services on a FACSymphony flow cytometer. The contract was awarded on September 1, 2017, with an ultimate completion date of September 1, 2018. This award was made without a small business set-aside designation, reflecting BD's established competitive position in the federal medical technology marketplace. The work was performed in East Lansing, Michigan. This purchase order represents routine maintenance and repair support for sophisticated laboratory instrumentation, consistent with BD Biosciences' primary role as a provider of flow cytometry equipment and technical services to federal healthcare and research institutions. BD maintains an extensive contract portfolio across multiple federal agencies, including the Department of Veterans Affairs, National Institutes of Health, and Centers for Disease Control and Prevention, demonstrating its capabilities in supplying specialized biomedical research technologies and associated support services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 9/1/17 |